GRIP Molecular Technologies is dedicated to advancing rapid, point-of-care molecular detection of chemical and biological threats. The Minnesota-based company is developing a proprietary electronic biosensor that leverages enhanced-graphene technology to detect a wide range of biomarkers in a single test. Their innovative approach aims to bring lab-quality diagnostics to at-home settings, making advanced healthcare more accessible and efficient.
GRIP Molecular Technologies has achieved significant milestones, including a collaborative development with Molecular Testing Labs to create an at-home disease testing platform. Their breakthrough technology integrates molecular biology with solid-state electronics, positioning them at the forefront of next-generation diagnostics. The company's patented platform exemplifies their commitment to revolutionizing the field of molecular diagnostics.
